RecruitingNCT05459402
Once- or twice-daily methadone for pain during opioid-use treatment
About this title
Read the official source — NCT05459402Medication studyAges 18–100United StatesAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 100 years.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 21, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 150
- Sponsor
- University of Maryland, Baltimore
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- United States
- Age range
- From 18 Years to 100 Years
- Official registry ID
- NCT05459402
- Official title
Show the full official title
Divided or Single Exposure (DOSE) Study: Randomized Controlled Trial for Pain in Persons Receiving Methadone Treatment
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Maryland, Baltimore, a university.
Does this study involve medication?
Yes. The study involves medication, including Methadone (100% dose) and Methadone (50% dose).
Who can participate?
Listed age limits: 18 years to 100 years.
Is this study still recruiting?
The registry lists this study as recruiting.
